logo

Biotechnology News

Share SHARE
Sanofi (SNYNF, SNY) announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) recommended the approval of the New Drug Application or NDA for the investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1...
Allergan plc (AGN) said that the Japanese Ministry of Health, Labour and Welfare has approved an additional use for BOTOX Vista (Allergan's botulinum toxin type A product) as a treatment for crow's feet lines (CFL). BOTOX Vista is now indicated for the temporary improvement in the appearance of lateral...
Seqirus, part of CSL Limited (CSL.AX), said that the US Food and Drug Administration has approved Flucelvax Quadrivalent or Influenza Vaccine, the first four-strain, cell culture-derived, inactivated seasonal influenza vaccine for people aged four years and older.FLUCELVAX QUADRIVALENT helps protect...
More
Pharma2-052416.jpg Shares of Innocoll (INNL) rose as much as 70% on Wednesday, following positive results from two phase III pivotal studies evaluating XARACOLL as a postoperative pain relief treatment immediately following open abdominal hernia repair.
FDA-thumb-042916.jpg After being voted down by an FDA panel last month, Sarepta Therapeutics Inc.'s (SRPT) Duchenne Muscular Dystrophy drug candidate Eteplirsen awaits the regulatory agency's final decision, which is set for May 26, 2016.
Pharma-052416.jpg Novo Nordisk's IDegLira, which is a combination of an ultralong acting basal insulin analogue Insulin degludec and glucagonlike peptide 1 agonist Liraglutide, for the treatment of type 2 diabetes, is all set to be reviewed by an FDA advisory panel on May 24, 2016.
More

OrganicPastures-052416.jpg

Raw milk, raw skim milk and raw cream produced by Organic Pastures Dairy of Fresno County are being recalled due to contamination with the deadly Salmonella bacteria. The recalled products have a USE BY date of JUN 01 2016, according to the California department of Food & Agriculture.

Quakeroats-051716.jpg

The Quaker Oats Co., a subsidiary of PepsiCo Inc., is recalling a small quantity of Quaker Quinoa Granola Bars due to potential contamination with the deadly bacterium Listeria monocytogenes.

Recalls-051616.jpg

Global restaurateur HMSHost of Bethesda, Maryland is recalling multiple brands of Cape Cod Cranberry trail mix due to potential contamination with the deadly bacterium Listeria monocytogenes.

SaladRecall-051116.jpg

WCD Kitchen LLC of Fontana, California is voluntarily recalling Trader Joe's Kale & Edamame Salad, sold only in the Midwest, due to potential contamination with the deadly Salmonella bacteria.

More
Date Company Name Ticker Drug Event Outcome Details
11/12/2016 Gilead Sciences Inc. GILD Tenofovir Alafenamide (TAF) (NDA) FDA decision on TAF for treatment of chronic hepatitis B
11/05/2016 Amgen Inc. AMGN Enbrel (sBLA) FDA decision on Enbrel for the expanded use to treat pediatric patients with chronic severe plaque psoriasis.
10/30/2016 Regeneron Pharmaceuticals REGN Sarilumab (BLA) FDA decision on Sarilumab for the treatment of patients with rheumatoid arthritis
10/30/2016 Sanofi SNYNF, SNY Sarilumab (BLA) FDA decision on Sarilumab for the treatment of patients with rheumatoid arthritis.
10/30/2016 Regeneron Pharmaceuticals REGN Sarilumab (BLA) FDA decision on Sarilumab for the treatment of patients with active, moderate-to-severe rheumatoid arthritis
More
Results Date Company Name Ticker Event Indication Outcome
01-Aug-2016 To 30-Sep-2016 MediciNova Inc MNOV, MNOV Interim efficacy analysis of Phase 2b Trial of MN-166 Progressive multiple sclerosis
Aug 2016 Auris Medical Holding AG EARS First topline phase 3 trial data for AM-101 (TACTT2) Acute inner ear tinnitus
2H 2016 RedHill Biopharma Ltd. RDHL Interim analysis of phase 3 study of RHB-104 Crohn’s disease
2H 2016 RedHill Biopharma Ltd. RDHL Topline results from phase 3 study of BEKINDA Gastroenteritis
Q3 2016 Array BioPharma Inc. ARRY Topline results from phase 3 trial of Binimetinib (COLUMBUS) BRAF-mutant melanoma
More
Prescriptions of opioids have dropped in the U.S. for the first time in twenty years, according to a new study from researchers at research group IMS Health. The firm finds that opioid prescriptions have dipped about 12 percent since 2014 and declines in prescriptions have occurred in 49 states since 2013. "The deaths are still - have still been rising."
Adults who were born as pre-term babies often have lower incomes and fewer sexual encounters, according to a new study from researchers at McMaster University in Ontario. For the study the researchers reviewed data collected on 189 adults born between 1977 and 1982. They found that by their mid-20's those born pre-term were making on-average $20,000 less per year than the term babies.
More